{"cursor":"5483","size":15,"audio":[],"currentlang":"en","article":"\nThe United States Food and Drug Administration's 'Investigational New Drug'\n('IND') program is the means by which a pharmaceutical company obtains\npermission to ship an experimental drug across state lines (usually to clinical\ninvestigators) before a marketing application for the drug has been approved.\nThe FDA reviews the IND application for safety to assure that research subjects\nwill not be subjected to unreasonable risk. If the application is cleared, the\ncandidate drug usually enters a Phase 1 clinical trial.\n","linknr":149,"url":"Investigational_New_Drug","recorded":1362891655,"links":13,"instances":["biochemistry"],"pdf":["http://www.fda.gov/cder/guidance/959fnl.pdf"],"categories":["Medical research","Food and Drug Administration","Drug safety"],"headings":["Criteria for application","Application contents","IND types","Additional regulations","Noteworthy examples","See also","References"],"image":["//upload.wikimedia.org/wikipedia/commons/thumb/a/a9/Ritalin-SR-20mg-1000x1000.jpg/220px-Ritalin-SR-20mg-1000x1000.jpg","//bits.wikimedia.org/static-1.21wmf10/skins/vector/images/search-ltr.png?303-4","//bits.wikimedia.org/images/wikimedia-button.png","//bits.wikimedia.org/static-1.21wmf10/skins/common/images/poweredby_mediawiki_88x31.png"],"tags":[["dose","biochemistry"]],"members":["dose"],"related":["Food_and_Drug_Administration","Pharmaceutical_industry","Interstate_commerce","Clinical_trial","Route_of_administration","Dose_(biochemistry)","Population","HIV_positive","Immunocompromised","Chemical_stability","Medical_marijuana","Compassionate_Investigational_New_Drug_program","AIDS","Cannabis","Abigail_Alliance_for_Better_Access_to_Developmental_Drugs","Drug_Discovery","Expanded_access","FDA_Fast_Track_Development_Program","Inverse_benefit_law","New_drug_application"]}